News

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the ...
However, beneath this success lies a growing concern: the sustainability of this growth trajectory, particularly as ...
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...
Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...
Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...
Merck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is ...
Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...